<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03885258</url>
  </required_header>
  <id_info>
    <org_study_id>30460114.5.0000.0068</org_study_id>
    <nct_id>NCT03885258</nct_id>
  </id_info>
  <brief_title>Melatonin Replacement Therapy in Pinealectomized Patients</brief_title>
  <official_title>Melatonin Replacement Therapy Effects on Cardiac Autonomic Activity in Pinealectomized Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open-label, single-arm, single-center, proof-of-concept study to assess the
      effects of melatonin on cardiac autonomic activity in melatonin non-proficient
      pinealectomized patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an open-label, single-arm, single-center, proof-of-concept study to assess the
      effects of melatonin on cardiac autonomic activity in melatonin non-proficient
      pinealectomized patients. The study consists of a screening period, followed by a 3-month
      melatonin treatment period, and a 6-month washout follow-up period. Adverse events were
      monitored with respect to seriousness, intensity, relationship to treatment, action taken and
      outcome of the event.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2, 2017</start_date>
  <completion_date type="Actual">February 28, 2019</completion_date>
  <primary_completion_date type="Actual">November 30, 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This is an open-label, single-arm, single-center, proof-of-concept study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cardiac autonomic function - heart rate variability</measure>
    <time_frame>9 months</time_frame>
    <description>The cardiac autonomic function was determined through heart rate variability (HRV) measures after polysomnography ECG recordings.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Pineal Tumor</condition>
  <arm_group>
    <arm_group_label>Melatonin Replacement Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Melatonin (Aché Pharmaceutics, Brazil) 3 mg, administered in the evening, 30 minutes before the usual bedtime, every day for 3 months. After discontinuation of melatonin therapy, patients are followed up for 6 months to assess safety parameters and cardiac autonomic activity.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin Replacement Therapy</intervention_name>
    <description>Melatonin (Aché Pharmaceutics, Brazil), 3 mg, administered in the evening, 30 minutes before the usual bedtime, every day for 3 months. After discontinuation of melatonin therapy, patients are followed up for 6 months to assess safety parameters and cardiac autonomic activity.</description>
    <arm_group_label>Melatonin Replacement Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with pinealectomy and all of the following criteria were considered for
             admission to the clinical trial:

          -  children, adolescents and young adults 0 months to 25 years of age;

          -  signed written informed consent (patient or his/her parents/legal guardian);

          -  willing and able to complete the clinical trial procedures, as described in the
             protocol

          -  no recurring tumor after pinealectomy and subsequent chemotherapy

          -  absence of circulating melatonin evaluated by salivary melatonin Elisa assay

        Exclusion Criteria:

          -  patients with cardiac arrhythmias

          -  potentially non-compliant subjects judged by the investigator to be unsuitable for the
             study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of São Paulo</name>
      <address>
        <city>São Paulo</city>
        <state>Sao Paulo</state>
        <zip>05508-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Cipolla-Neto J, Amaral FGD. Melatonin as a Hormone: New Physiological and Clinical Insights. Endocr Rev. 2018 Dec 1;39(6):990-1028. doi: 10.1210/er.2018-00084. Review.</citation>
    <PMID>30215696</PMID>
  </reference>
  <reference>
    <citation>Baltatu OC, Amaral FG, Campos LA, Cipolla-Neto J. Melatonin, mitochondria and hypertension. Cell Mol Life Sci. 2017 Nov;74(21):3955-3964. doi: 10.1007/s00018-017-2613-y. Epub 2017 Aug 8. Review.</citation>
    <PMID>28791422</PMID>
  </reference>
  <reference>
    <citation>Campos LA, Cipolla-Neto J, Michelini LC. Melatonin modulates baroreflex control via area postrema. Brain Behav. 2013 Mar;3(2):171-7. doi: 10.1002/brb3.123. Epub 2013 Feb 17.</citation>
    <PMID>23531786</PMID>
  </reference>
  <reference>
    <citation>Pereira VL Jr, Dobre M, Dos Santos SG, Fuzatti JS, Oliveira CR, Campos LA, Brateanu A, Baltatu OC. Association between Carotid Intima Media Thickness and Heart Rate Variability in Adults at Increased Cardiovascular Risk. Front Physiol. 2017 Apr 26;8:248. doi: 10.3389/fphys.2017.00248. eCollection 2017.</citation>
    <PMID>28491040</PMID>
  </reference>
  <reference>
    <citation>Campos LA, Pereira VL Jr, Muralikrishna A, Albarwani S, Brás S, Gouveia S. Mathematical biomarkers for the autonomic regulation of cardiovascular system. Front Physiol. 2013 Oct 7;4:279. doi: 10.3389/fphys.2013.00279. Review.</citation>
    <PMID>24109456</PMID>
  </reference>
  <reference>
    <citation>Shaffer F, Ginsberg JP. An Overview of Heart Rate Variability Metrics and Norms. Front Public Health. 2017 Sep 28;5:258. doi: 10.3389/fpubh.2017.00258. eCollection 2017. Review.</citation>
    <PMID>29034226</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 20, 2019</study_first_submitted>
  <study_first_submitted_qc>March 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2019</study_first_posted>
  <last_update_submitted>March 20, 2019</last_update_submitted>
  <last_update_submitted_qc>March 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Anhembi Morumbi University</investigator_affiliation>
    <investigator_full_name>Ovidiu Constantin Baltatu</investigator_full_name>
    <investigator_title>Co-PI to PI - José Cipolla-Neto</investigator_title>
  </responsible_party>
  <keyword>melatonin</keyword>
  <keyword>pinealectomy</keyword>
  <keyword>Cardiac Autonomic System</keyword>
  <keyword>heart rate variability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pinealoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

